NFEC [NF Energy Saving] S-3/A: (Original Filing)

[AMENDMENT NO. 1 T O FORM S-3 REGISTRATION STATEMENT UNDER SECURITIES ACT OF 1933 NF ENERGY SAVING CORPORATION Delaware 02-0563302 (State or other jurisdiction of ( incorporation or organization) Identification No.) Room 3105, Block C, 390 Qingnian Avenue, HePing District Shenyang, P. R. China 110003 (8624) 8563-1159 (Address, including zip code, and telephone number, including The Company Corporation 2711 Centerville] [Consent of Independent Registered Public Accounting Firm The Board of Directors NF Energy Saving Corporation We consent to the incorporation by reference in Amendment No. 1 to the Registration Statement on Form S-3 of our report dated March 30, 2010 on our audit of the consolidated financial statements of NF Energy Saving Corporation (the “Company”) as of December 31, 2009]

NFEC [NF Energy Saving] S-3/A: AMENDMENT NO. 1 T O FORM S-3 REGISTRATION

[AMENDMENT NO. 1 T O FORM S-3 REGISTRATION STATEMENT UNDER SECURITIES ACT OF 1933 NF ENERGY SAVING CORPORATION Delaware 02-0563302 (State or other jurisdiction of ( incorporation or organization) Identification No.) Room 3105, Block C, 390 Qingnian Avenue, HePing District Shenyang, P. R. China 110003 (8624) 8563-1159 (Address, including zip code, and telephone number, including The Company Corporation 2711 Centerville] [Consent of Independent Registered Public Accounting Firm The Board of Directors NF Energy Saving Corporation We consent to the incorporation by reference in Amendment No. 1 to the Registration Statement on Form S-3 of our report dated March 30, 2010 on our audit of the consolidated financial statements of NF Energy Saving Corporation (the “Company”) as of December 31, 2009]

CPHI [CHINA PHARMAS,] 10-K/A: (Original Filing)

[FORM 10-K/A (Amendment No. 1) x For the fiscal year ended December 31, 2010 or ¨ For the transition period from _________ to _____________ 001-34471 China Pharma Holdings, Inc. Delaware 73-1564807 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 (011) 86 898-6681-1730 Common Stock, par] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-164049 on Form S-3 and Registration Statement No. 333-141734 Post-Effective Amendment No. 1 to Form SB-2 on Form S-3 of our report dated March 2, 2011 relating to the consolidated financial statements of China Pharma Holdings, Inc. and subsidiaries appearing in this] [CERTIFICATION (Section 302 of the Sarbanes-Oxley Act of 2002) I, Zhilin Li, certify that: 1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION (Section 302 of the Sarbanes-Oxley Act of 2002) I, Frank Waung, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b.] [CERTIFICATION (Section 906 of the Sarbanes-Oxley Act of 2002) (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Zhilin Li EX-32.1 8 cphi10kaex321123110.htm] [CERTIFICATION (Section 906 of the Sarbanes-Oxley Act of 2002) (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Frank Waung Chief Financial Officer (principal financial officer and principal accounting officer) EX-32.2 9 cphi10kaex322123110.htm]

By | 2016-03-03T19:39:04+00:00 March 17th, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-K/A: FORM 10-K/A (Amendment No. 1) x For the

[FORM 10-K/A (Amendment No. 1) x For the fiscal year ended December 31, 2010 or ¨ For the transition period from _________ to _____________ 001-34471 China Pharma Holdings, Inc. Delaware 73-1564807 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 (011) 86 898-6681-1730 Common Stock, par] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-164049 on Form S-3 and Registration Statement No. 333-141734 Post-Effective Amendment No. 1 to Form SB-2 on Form S-3 of our report dated March 2, 2011 relating to the consolidated financial statements of China Pharma Holdings, Inc. and subsidiaries appearing in this] [CERTIFICATION (Section 302 of the Sarbanes-Oxley Act of 2002) I, Zhilin Li, certify that: 1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION (Section 302 of the Sarbanes-Oxley Act of 2002) I, Frank Waung, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b.] [CERTIFICATION (Section 906 of the Sarbanes-Oxley Act of 2002) (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Zhilin Li EX-32.1 8 cphi10kaex321123110.htm] [CERTIFICATION (Section 906 of the Sarbanes-Oxley Act of 2002) (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Frank Waung Chief Financial Officer (principal financial officer and principal accounting officer) EX-32.2 9 cphi10kaex322123110.htm]

By | 2016-03-03T19:40:39+00:00 March 17th, 2011|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

GURE [GULF RESOURCES] 8-K: (Original Filing)

[Gulf Resources Reports Fourth Quarter and Fiscal Year 2010 Results New York & Shandong Province, March 17, 2010 Fourth Quarter Highlights · Revenue was $37.1 million, a year-over-year increase of 26.4% · Gross profit was $19.6 million, a year-over-year increase of 45.0% · Gross margin increased to 52.7% from 46.0% for the fourth quarter of 2009 · Income from operations] [Gulf Resources Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2010 Results Press Release SHOUGUANG CITY, China, March 16, 2011 /PRNewswire-Asia-FirstCall/ -- Gulf Resources, Inc. (NASDAQ:GFRE - News) ("Gulf Resources" or the "Company"), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced that the Company will host a conference call on Thursday,] [+86 (536) 567 0008 o o o o Item 2.02. Results of Operations and Financial Condition Item 8.01. Other Events. 99.1 Press Release of Gulf Resources, Inc. dated March 17, 2011. 99.2 Press Release of Gulf Resources, Inc. dated March 16, 2011.]

By | 2016-03-18T08:36:34+00:00 March 17th, 2011|Categories: Chinese Stocks, GURE, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar